{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:05:35Z","timestamp":1784815535626,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00405-025-09619-y","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:34:54Z","timestamp":1754339694000},"page":"4681-4690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Remission in chronic rhinosinusitis with nasal polyps treated with biologics: a real-life experience"],"prefix":"10.1007","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7174-8126","authenticated-orcid":false,"given":"Antonella","family":"Loperfido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0378-8935","authenticated-orcid":false,"given":"Carlo","family":"Cavaliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1468-459X","authenticated-orcid":false,"given":"Andrea","family":"Ciofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Bugani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6960-2822","authenticated-orcid":false,"given":"Elona","family":"Begvarfaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Millarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-3309","authenticated-orcid":false,"given":"Gianluca","family":"Bellocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-7820","authenticated-orcid":false,"given":"Marco","family":"de Vincentiis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0423-9505","authenticated-orcid":false,"given":"Simonetta","family":"Masieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"9619_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58:1\u2013464. https:\/\/doi.org\/10.4193\/Rhin20.600","journal-title":"Rhinology"},{"key":"9619_CR2","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jaip.2022.03.002","volume":"10","author":"J Mullol","year":"2022","unstructured":"Mullol J, Azar A, Buchheit KM, Hopkins C, Bernstein JA (2022) Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era. J Allergy Clin Immunol Pract 10:1434\u20131453. https:\/\/doi.org\/10.1016\/j.jaip.2022.03.002","journal-title":"J Allergy Clin Immunol Pract"},{"key":"9619_CR3","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.jaip.2020.03.007","volume":"8","author":"C Bachert","year":"2020","unstructured":"Bachert C, Marple B, Hosemann W, Cavaliere C, Wen W, Zhang N (2020) Endotypes of chronic rhinosinusitis with nasal polyps: pathology and possible therapeutic implications. J Allergy Clin Immunol Pract 8:1514\u20131519. https:\/\/doi.org\/10.1016\/j.jaip.2020.03.007","journal-title":"J Allergy Clin Immunol Pract"},{"key":"9619_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/JAA.S290424","volume":"14","author":"C Bachert","year":"2021","unstructured":"Bachert C, Bhattacharyya N, Desrosiers M, Khan AH (2021) Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy 14:127\u2013134. https:\/\/doi.org\/10.2147\/JAA.S290424","journal-title":"J Asthma Allergy"},{"key":"9619_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/jpm14030297","volume":"14","author":"C Cavaliere","year":"2024","unstructured":"Cavaliere C, Masieri S, Begvarfaj E, Loperfido A, Baroncelli S, Cascone F, Ciofalo A (2024) Long-Term perspectives on chronic rhinosinusitis with nasal polyps: evaluating recurrence rates after functional endoscopic sinus surgery in the biologics Era-A 5-Year Follow-Up study. J Pers Med 14:297. https:\/\/doi.org\/10.3390\/jpm14030297","journal-title":"J Pers Med"},{"key":"9619_CR6","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1007\/s00405-024-08958-6","volume":"281","author":"A Ciofalo","year":"2024","unstructured":"Ciofalo A, Loperfido A, Baroncelli S, Masieri S, Bellocchi G, Caramia R, Cascone F, Filaferro L, Lo Re F, Cavaliere C (2024) Comparison between clinical and cytological findings in chronic rhinosinusitis with nasal polyps treated with dupilumab. Eur Arch Otorhinolaryngol 281:6511\u20136521. https:\/\/doi.org\/10.1007\/s00405-024-08958-6","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"9619_CR7","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394:1638\u20131650. https:\/\/doi.org\/10.1016\/S0140-6736(19)31881-1","journal-title":"Lancet"},{"key":"9619_CR8","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1111\/all.15772","volume":"78","author":"E De Corso","year":"2023","unstructured":"De Corso E, Pasquini E, Trimarchi M et al (2023) Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational phase IV real-life study (DUPIREAL). Allergy 78:2669\u20132683. https:\/\/doi.org\/10.1111\/all.15772","journal-title":"Allergy"},{"key":"9619_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jaci.2024.10.016","volume":"155","author":"SF Seys","year":"2025","unstructured":"Seys SF, Schneider S, de Kinderen J et al (2025) Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR). J Allergy Clin Immunol 155:451\u2013460. https:\/\/doi.org\/10.1016\/j.jaci.2024.10.016","journal-title":"J Allergy Clin Immunol"},{"key":"9619_CR10","doi-asserted-by":"publisher","first-page":"e2023227","DOI":"10.23750\/abm.v94i5.14745","volume":"94","author":"G Bellocchi","year":"2023","unstructured":"Bellocchi G, Loperfido A, Passali FM, Millarelli S, Velletrani G, Perla M, Di Michele L, Di Girolamo S (2023) Biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: A bicentric experience. Acta Biomed 94:e2023227. https:\/\/doi.org\/10.23750\/abm.v94i5.14745","journal-title":"Acta Biomed"},{"key":"9619_CR11","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.3390\/jcm13123575","volume":"13","author":"C Cavaliere","year":"2024","unstructured":"Cavaliere C, Loperfido A, Ciofalo A, Di Michele L, Begvarfaj E, Bellocchi G, Bugani M, de Vincentiis M, Greco A, Millarelli S, Plath M, Sculco E, Masieri S (2024) Real-Life evidence of mepolizumab treatment in chronic rhinosinusitis with nasal polyps: A multicentric study. J Clin Med 13:3575. https:\/\/doi.org\/10.3390\/jcm13123575","journal-title":"J Clin Med"},{"key":"9619_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.14639\/0392-100X-suppl.1-43-2023-01","volume":"43","author":"E De Corso","year":"2023","unstructured":"De Corso E, Settimi S, Montuori C, Cantiani A, Corb\u00f2 M, Di Bella GA, Sovardi F, Pagella F, Rigante M, Passali GC, Paludetti G, Galli J (2023) How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review. Acta Otorhinolaryngol Ital 43:3\u201313. https:\/\/doi.org\/10.14639\/0392-100X-suppl.1-43-2023-01","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"9619_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4193\/Rhin23.415","volume":"62","author":"WJ Fokkens","year":"2024","unstructured":"Fokkens WJ, De Corso E, Backer V, Bernal-Sprekelsen M, Bjermer L, von Buchwald C, Chaker A, Diamant Z, Gevaert P, Han J, Hopkins C, Hox V, Klimek L, Lund VJ, Lee S, Luong A, Mullol J, Peters A, Pfaar O, Reitsma S, Toppila-Salmi S, Scadding GK, Sedaghat AR, Viskens AS, Wagenmann M, Hellings PW (2024) EPOS2020\/EUFOREA expert opinion on defining disease States and therapeutic goals in CRSwNP. Rhinology 62:287\u2013298. https:\/\/doi.org\/10.4193\/Rhin23.415","journal-title":"Rhinology"},{"key":"9619_CR14","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1111\/all.15507","volume":"77","author":"X Xu","year":"2022","unstructured":"Xu X, Reitsma S, Wang Y, Fokkens WJ (2022) Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID-exacerbated respiratory disease. Allergy 77:3593\u20133605. https:\/\/doi.org\/10.1111\/all.15507","journal-title":"Allergy"},{"key":"9619_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14639\/0392-100X-N1614","volume":"42","author":"E De Corso","year":"2022","unstructured":"De Corso E, Bellocchi G, De Benedetto M, Lombardo N, Macchi A, Malvezzi L, Motta G, Pagella F, Vicini C, Passali D (2022) Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the joint committee of Italian society of otorhinolaryngology on biologics in rhinology. Acta Otorhinolaryngol Ital 42:1\u201316. https:\/\/doi.org\/10.14639\/0392-100X-N1614","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"9619_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaci.2006.09.005","volume":"118","author":"EO Meltzer","year":"2006","unstructured":"Meltzer EO, Hamilos DL, Hadley JA et al (2006) Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 118:17\u201361. https:\/\/doi.org\/10.1016\/j.jaci.2006.09.005","journal-title":"J Allergy Clin Immunol"},{"key":"9619_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00405-016-4313-x","volume":"274","author":"F Mozzanica","year":"2017","unstructured":"Mozzanica F, Preti A, Gera R, Gallo S, Bulgheroni C, Bandi F, Ottaviani F, Castelnuovo P (2017) Cross-cultural adaptation and validation of the SNOT-22 into Italian. Eur Arch Otorhinolaryngol 274:887\u2013895. https:\/\/doi.org\/10.1007\/s00405-016-4313-x","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"9619_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13601-018-0219-6","volume":"8","author":"M Doulaptsi","year":"2018","unstructured":"Doulaptsi M, Prokopakis E, Seys S, Pugin B, Steelant B, Hellings P (2018) Visual analogue scale for sino-nasal symptoms severity correlates with sino-nasal outcome test 22: paving the way for a simple outcome tool of CRS burden. Clin Transl Allergy 8:32. https:\/\/doi.org\/10.1186\/s13601-018-0219-6","journal-title":"Clin Transl Allergy"},{"key":"9619_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4193\/Rhin21.446","volume":"60","author":"KM Phillips","year":"2022","unstructured":"Phillips KM, Singerman KW, Sedaghat AR (2022) Individual symptom visual analogue scale severity scores for determining EPOS guideline-based chronic rhinosinusitis disease control. Rhinology 60:229\u2013235. https:\/\/doi.org\/10.4193\/Rhin21.446","journal-title":"Rhinology"},{"key":"9619_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4193\/Rhin21.275","volume":"61","author":"DAE Dietz de Loos","year":"2023","unstructured":"Dietz de Loos DAE, Cornet ME, Hopkins C, Fokkens WJ, Reitsma S (2023) Measuring control of disease in chronic rhinosinusitis; assessing the correlation between sinonasal outcome Test-22 and visual analogue scale item scores. Rhinology 61:39\u201346. https:\/\/doi.org\/10.4193\/Rhin21.275","journal-title":"Rhinology"},{"key":"9619_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4193\/Rhin24.291","volume":"63","author":"AR Sedaghat","year":"2025","unstructured":"Sedaghat AR, Cotter RA, Alobid I et al (2025) Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control. Rhinology 63:54\u201362. https:\/\/doi.org\/10.4193\/Rhin24.291","journal-title":"Rhinology"},{"key":"9619_CR22","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/alr.22944","volume":"12","author":"PW Hellings","year":"2022","unstructured":"Hellings PW, Peters AT, Chaker AM, Heffler E, Zhang H, Praestgaard A, Nash S, Khan AH, Siddiqui S, Jacob-Nara JA, Rowe PJ, Deniz Y (2022) Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 12:958\u2013962. https:\/\/doi.org\/10.1002\/alr.22944","journal-title":"Int Forum Allergy Rhinol"},{"key":"9619_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11882-025-01192-y","volume":"25","author":"M Rodriguez-Iglesias","year":"2025","unstructured":"Rodriguez-Iglesias M, Calvo-Henr\u00edquez C, Martin-Jimenez D, Garc\u00eda-Lliber\u00f3s A, Maza-Solano J, Moreno-Luna R, Izquierdo-Dom\u00ednguez A, Mart\u00ednez-Capoccioni G, Alobid I (2025) Effect of dupilumab in CRSwNP sinonasal outcomes from real life studies: A systematic review with Meta-analysis. Curr Allergy Asthma Rep 25:13. https:\/\/doi.org\/10.1007\/s11882-025-01192-y","journal-title":"Curr Allergy Asthma Rep"},{"key":"9619_CR24","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1111\/all.15796","volume":"78","author":"RJL van der Lans","year":"2023","unstructured":"van der Lans RJL, Otten JJ, Adriaensen GFJPM, Hoven DR, Benoist LB, Fokkens WJ, Reitsma S (2023) Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months. Allergy 78:2684\u20132697. https:\/\/doi.org\/10.1111\/all.15796","journal-title":"Allergy"},{"key":"9619_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11882-023-01118-6","volume":"24","author":"M Caminati","year":"2024","unstructured":"Caminati M, De Corso E, Ottaviano G, Pipolo C, Schiappoli M, Seccia V, Spinelli FR, Savarino EV, Gisondi P, Senna G (2024) Remission in type 2 inflammatory diseases: current evidence, unmet needs, and suggestions for defining remission in chronic rhinosinusitis with nasal polyps. Curr Allergy Asthma Rep 24:11\u201323. https:\/\/doi.org\/10.1007\/s11882-023-01118-6","journal-title":"Curr Allergy Asthma Rep"},{"key":"9619_CR26","doi-asserted-by":"publisher","first-page":"1019255","DOI":"10.3389\/falgy.2022.1019255","volume":"3","author":"A Atanasio","year":"2022","unstructured":"Atanasio A, Orengo JM, Sleeman MA, Stahl N (2022) Biologics as novel therapeutics for the treatment of allergy: challenges and opportunities. Front Allergy 3:1019255. https:\/\/doi.org\/10.3389\/falgy.2022.1019255","journal-title":"Front Allergy"},{"key":"9619_CR27","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/j.jaip.2022.05.019","volume":"10","author":"ME Wechsler","year":"2022","unstructured":"Wechsler ME, Klion AD, Paggiaro P, Nair P, Staumont-Salle D, Radwan A, Johnson RR, Kapoor U, Khokhar FA, Daizadeh N, Chen Z, Laws E, Ortiz B, Jacob-Nara JA, Mannent LP, Rowe PJ, Deniz Y (2022) Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis. J Allergy Clin Immunol Pract 10:2695\u20132709. https:\/\/doi.org\/10.1016\/j.jaip.2022.05.019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"9619_CR28","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1111\/all.15844","volume":"78","author":"FS Ryser","year":"2023","unstructured":"Ryser FS, Yalamanoglu A, Valaperti A, Br\u00fchlmann C, Mauthe T, Traidl S, Soyka MB, Steiner UC (2023) Dupilumab-induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis. Allergy 78:2712\u20132723. https:\/\/doi.org\/10.1111\/all.15844","journal-title":"Allergy"},{"key":"9619_CR29","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/all.14151","volume":"75","author":"A Le Floc\u2019h","year":"2020","unstructured":"Le Floc\u2019h A, Allinne J, Nagashima K et al (2020) Dual Blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation. Allergy 75:1188\u20131204. https:\/\/doi.org\/10.1111\/all.14151","journal-title":"Allergy"},{"key":"9619_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-pathol-052016-100401","volume":"12","author":"RP Schleimer","year":"2017","unstructured":"Schleimer RP (2017) Immunopathogenesis of chronic rhinosinusitis and nasal polyposis. Annu Rev Pathol 12:331\u2013357. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100401","journal-title":"Annu Rev Pathol"},{"key":"9619_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.14639\/0392-100X-N1911","volume":"42","author":"L Nitro","year":"2022","unstructured":"Nitro L, Bulfamante AM, Rosso C, Saibene AM, Arnone F, Felisati G, Pipolo C (2022) Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review. Acta Otorhinolaryngol Ital 42:199\u2013204. https:\/\/doi.org\/10.14639\/0392-100X-N1911","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"9619_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jaip.2024.10.009","volume":"13","author":"ID Pavord","year":"2025","unstructured":"Pavord ID, Rabe KF, Israel E, Szefler SJ, Brusselle G, Pandit-Abid N, Altincatal A, Chen Z, Amin N, Khan AH, Lederer DJ, Zhang Y, Rowe PJ, Deniz Y, Radwan A, Jacob-Nara JA, Busse WW (2025) Dupilumab induces Long-Term On-Treatment clinical remission in patients with type 2 asthma. J Allergy Clin Immunol Pract 13:132\u2013142. https:\/\/doi.org\/10.1016\/j.jaip.2024.10.009","journal-title":"J Allergy Clin Immunol Pract"},{"key":"9619_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/jcm13010291","volume":"13","author":"CMI Quarato","year":"2024","unstructured":"Quarato CMI, Tondo P, Lacedonia D, Soccio P, Fuso P, Sabato E, Hoxhallari A, Foschino Barbaro MP, Scioscia G (2024) Clinical remission in patients affected by severe eosinophilic asthma on dupilumab therapy: A Long-Term Real-Life study. J Clin Med 13:291. https:\/\/doi.org\/10.3390\/jcm13010291","journal-title":"J Clin Med"},{"key":"9619_CR34","first-page":"144","volume":"45","author":"M Lim","year":"2007","unstructured":"Lim M, Lew-Gor S, Darby Y, Brookes N, Scadding G, Lund VJ (2007) The relationship between subjective assessment instruments in chronic rhinosinusitis. Rhinology 45:144\u2013147","journal-title":"Rhinology"},{"key":"9619_CR35","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jaip.2021.09.037","volume":"10","author":"J Mullol","year":"2022","unstructured":"Mullol J, Bachert C, Amin N, Desrosiers M, Hellings PW, Han JK, Jankowski R, Vodicka J, Gevaert P, Daizadeh N, Khan AH, Kamat S, Patel N, Graham NMH, Ruddy M, Staudinger H, Mannent LP (2022) Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 10:1086\u20131095. https:\/\/doi.org\/10.1016\/j.jaip.2021.09.037","journal-title":"J Allergy Clin Immunol Pract"},{"key":"9619_CR36","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1002\/lary.24654","volume":"124","author":"AJ Psaltis","year":"2014","unstructured":"Psaltis AJ, Li G, Vaezeafshar R, Cho KS, Hwang PH (2014) Modification of the Lund-Kennedy endoscopic scoring system improves its reliability and correlation with patient-reported outcome measures. Laryngoscope 124:2216\u20132223. https:\/\/doi.org\/10.1002\/lary.24654","journal-title":"Laryngoscope"},{"key":"9619_CR37","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/all.15650","volume":"78","author":"P Gevaert","year":"2023","unstructured":"Gevaert P, De Craemer J, Bachert C et al (2023) European academy of allergy and clinical immunology position paper on endoscopic scoring of nasal polyposis. Allergy 78:912\u2013922. https:\/\/doi.org\/10.1111\/all.15650","journal-title":"Allergy"},{"key":"9619_CR38","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.3390\/life13112165","volume":"13","author":"R Cergan","year":"2023","unstructured":"Cergan R, Berghi ON, Dumitru M, Vrinceanu D, Manole F, Serboiu CS (2023) Biologics for chronic Rhinosinusitis-A modern option for therapy. Life (Basel) 13:2165. https:\/\/doi.org\/10.3390\/life13112165","journal-title":"Life (Basel)"},{"key":"9619_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/1744666X.2017.1298443","volume":"13","author":"NA Gandhi","year":"2017","unstructured":"Gandhi NA, Pirozzi G, Graham NMH (2017) Commonality of the IL-4\/IL-13 pathway in atopic diseases. Expert Rev Clin Immunol 13:425\u2013437. https:\/\/doi.org\/10.1080\/1744666X.2017.1298443","journal-title":"Expert Rev Clin Immunol"},{"key":"9619_CR40","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/JAA.S355391","volume":"15","author":"C Bachert","year":"2022","unstructured":"Bachert C, Khan AH, Hopkins C, Blaiss MS, Soler ZM, Nash S, Siddiqui S, Praestgaard A, Deniz Y, Rowe PJ, Jacob-Nara JA (2022) Rapid and continuing improvements in nasal symptoms with dupilumab in patients with severe CRSwNP. J Asthma Allergy 15:557\u2013563. https:\/\/doi.org\/10.2147\/JAA.S355391","journal-title":"J Asthma Allergy"},{"key":"9619_CR41","doi-asserted-by":"publisher","first-page":"100780","DOI":"10.1016\/j.waojou.2023.100780","volume":"16","author":"T Albrecht","year":"2023","unstructured":"Albrecht T, Sailer MM, Capitani F, van Schaik C, L\u00f6wenheim H, Becker S (2023) Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy. World Allergy Organ J 16:100780. https:\/\/doi.org\/10.1016\/j.waojou.2023.100780","journal-title":"World Allergy Organ J"},{"key":"9619_CR42","doi-asserted-by":"publisher","unstructured":"Loperfido A, Ciofalo A, Cavaliere C, Begvarfaj E, Cascone F, Alfonzo G, Cadeddu R, Millarelli S, Bellocchi G, Greco A, de Vincentiis M, Masieri S (2023) Dupilumab\u2019s impact on blood parameters in nasal polyposis: 18-month follow-up in real life. J Immunol Res 2023(4027701). https:\/\/doi.org\/10.1155\/2023\/4027701","DOI":"10.1155\/2023\/4027701"},{"key":"9619_CR43","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","volume":"145","author":"A Menzies-Gow","year":"2020","unstructured":"Menzies-Gow A, Bafadhel M, Busse WW, Casale TB, Kocks JWH, Pavord ID, Szefler SJ, Woodruff PG, de Giorgio-Miller A, Trudo F, Fageras M, Ambrose CS (2020) An expert consensus framework for asthma remission as a treatment goal. J Allergy Clin Immunol 145:757\u2013765. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.006","journal-title":"J Allergy Clin Immunol"},{"key":"9619_CR44","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1053\/j.gastro.2020.07.039","volume":"159","author":"A Straumann","year":"2020","unstructured":"Straumann A, Lucendo AJ, Miehlke S et al (2020) Budesonide orodispersible tablets maintain remission in a randomized, Placebo-Controlled trial of patients with eosinophilic esophagitis. Gastroenterology 159:1672\u20131685. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.039","journal-title":"Gastroenterology"},{"key":"9619_CR45","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2340\/00015555-1941","volume":"95","author":"L von Kobyletzki","year":"2015","unstructured":"von Kobyletzki L, Svensson \u00c5, Apfelbacher C, Schmitt J (2015) Factors that predict remission of infant atopic dermatitis: a systematic review. Acta Derm Venereol 95:389\u2013394. https:\/\/doi.org\/10.2340\/00015555-1941","journal-title":"Acta Derm Venereol"},{"key":"9619_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s13555-020-00475-8","volume":"11","author":"P Gisondi","year":"2021","unstructured":"Gisondi P, Talamonti M, Chiricozzi A et al (2021) Treat-to-Target approach for the management of patients with Moderate-to-Severe plaque psoriasis: consensus recommendations. Dermatol Ther (Heidelb) 11:235\u2013252. https:\/\/doi.org\/10.1007\/s13555-020-00475-8","journal-title":"Dermatol Ther (Heidelb)"},{"key":"9619_CR47","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/ecco-jcc\/jjz131","volume":"14","author":"JF Colombel","year":"2020","unstructured":"Colombel JF, D\u2019haens G, Lee WJ, Petersson J, Panaccione R (2020) Outcomes and strategies to support a Treat-to-target approach in inflammatory bowel disease: A systematic review. J Crohns Colitis 14:254\u2013266. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz131","journal-title":"J Crohns Colitis"},{"key":"9619_CR48","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69:631\u2013637. https:\/\/doi.org\/10.1136\/ard.2009.123919","journal-title":"Ann Rheum Dis"},{"key":"9619_CR49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4193\/Rhin24.457","volume":"63","author":"PW Hellings","year":"2025","unstructured":"Hellings PW, De Corso E, Backer V, Bernal-Sprekelsen M, Chan Y, Conti DM, Cornet ME, Fokkens WJ, Gevaert P, Han J, Hopkins C, Landis BN, Lau S, Lee S, Lund VJ, Mullol J, Peters A, Schneider S, Senior B (2025) Remission in chronic rhinosinusitis with nasal polyps (CRSwNP). Rhinology 63:239\u2013241. https:\/\/doi.org\/10.4193\/Rhin24.457","journal-title":"Rhinology"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09619-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-025-09619-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09619-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T20:04:52Z","timestamp":1757534692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-025-09619-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["9619"],"URL":"https:\/\/doi.org\/10.1007\/s00405-025-09619-y","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}